Literature DB >> 33203058

M Mode Ultrasound and Tissue Doppler Imaging to Assess Diaphragm Feature in Late Onset Pompe Disease.

Paris Meng1, Adam Ogna1, Abdallah Fayssoil2.   

Abstract

Late-onset Pompe disease (LOPD) is an autosomal recessive lysosomal storage disease. Clinical features include skeletal muscle deficiency and diaphragm weakness. Clinical management relies on supportive treatment and mechanical ventilation in patients with chronic respiratory failure. M mode ultrasound and sniff tissue Doppler imaging can be used to assess and follow diaphragm function.

Entities:  

Keywords:  LOPD; diaphragm; ultrasound

Year:  2020        PMID： 33203058      PMCID： PMC7768541          DOI： 10.3390/neurolint12030012

Source DB:  PubMed          Journal:  Neurol Int        ISSN： 2035-8385


  10 in total

1.  Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease.

Authors:  M Boentert; N Karabul; S Wenninger; B Stubbe-Dräger; E Mengel; B Schoser; P Young
Journal:  Eur J Neurol       Date:  2014-11-04       Impact factor: 6.089

2.  Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders.

Authors:  C Fromageot; F Lofaso; D Annane; L Falaize; M Lejaille; B Clair; P Gajdos; J C Raphaël
Journal:  Arch Phys Med Rehabil       Date:  2001-01       Impact factor: 3.966

3.  Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease.

Authors:  N A M E van der Beek; C I van Capelle; K I van der Velden-van Etten; W C J Hop; B van den Berg; A J J Reuser; P A van Doorn; A T van der Ploeg; H Stam
Journal:  Mol Genet Metab       Date:  2011-06-24       Impact factor: 4.797

4.  Assessing inspiratory muscle strength in patients with neurologic and neuromuscular diseases : comparative evaluation of two noninvasive techniques.

Authors:  I Iandelli; M Gorini; G Misuri; F Gigliotti; E Rosi; R Duranti; G Scano
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

5.  The nature of respiratory muscle weakness in patients with late-onset Pompe disease.

Authors:  Jens Spiesshoefer; Carolin Henke; Hans Joachim Kabitz; Tobias Brix; Dennis Görlich; Simon Herkenrath; Winfried Randerath; Peter Young; Matthias Boentert
Journal:  Neuromuscul Disord       Date:  2019-06-22       Impact factor: 4.296

6.  Respiratory failure in Pompe disease: treatment with noninvasive ventilation.

Authors:  U Mellies; F Stehling; C Dohna-Schwake; R Ragette; H Teschler; T Voit
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

7.  Sleep-Disordered Breathing and Effects of Noninvasive Ventilation in Patients with Late-Onset Pompe Disease.

Authors:  Matthias Boentert; Bianca Dräger; Christian Glatz; Peter Young
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

Review 8.  Pompe disease: a neuromuscular disease with respiratory muscle involvement.

Authors:  Uwe Mellies; Frédéric Lofaso
Journal:  Respir Med       Date:  2009-01-07       Impact factor: 3.415

9.  Pompe disease diagnosis and management guideline.

Authors:  Priya S Kishnani; Robert D Steiner; Deeksha Bali; Kenneth Berger; Barry J Byrne; Laura E Case; Laura Case; John F Crowley; Steven Downs; R Rodney Howell; Richard M Kravitz; Joanne Mackey; Deborah Marsden; Anna Maria Martins; David S Millington; Marc Nicolino; Gwen O'Grady; Marc C Patterson; David M Rapoport; Alfred Slonim; Carolyn T Spencer; Cynthia J Tifft; Michael S Watson
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

10.  Diaphragm sniff ultrasound: Normal values, relationship with sniff nasal pressure and accuracy for predicting respiratory involvement in patients with neuromuscular disorders.

Authors:  Abdallah Fayssoil; Lee S Nguyen; Adam Ogna; Tanya Stojkovic; Paris Meng; Dominique Mompoint; Robert Carlier; Helene Prigent; Bernard Clair; Anthony Behin; Pascal Laforet; Guillaume Bassez; Pascal Crenn; David Orlikowski; Djillali Annane; Bruno Eymard; Frederic Lofaso
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.